Related Experiment Video
Updated: Sep 11, 2026

A Real-World High-Intensity Interval Training Protocol for Cardiorespiratory Fitness Improvement
Published on: February 22, 2022
High intensity interval training in interstitial lung disease: a randomized controlled trial
Leona Dowman1,2,3,4, Anthony K May1, Catherine J Hill3,4
1Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.
Rationale:
Pulmonary rehabilitation (PR) is an effective guideline-recommended intervention for people with interstitial lung disease (ILD). However, not all participants experience clinically meaningful improvements. The current PR approach may not represent the optimal form of exercise training for people with ILD.
Objectives:
To compare the effects of high intensity interval training (HIIT) with the standard PR method of moderate intensity continuous training (MICT) in fibrotic ILD (fILD).
Methods:
131 participants with fILD were randomized, stratified for exertional desaturation (SpO2 < or ≥ 90%), to undertake HIIT or MICT during a standard 8-week, twice-weekly PR program. Cycle endurance time (primary outcome), 6-minute walk distance (6MWD), symptoms, health-related quality of life, skeletal muscle changes, and physical activity levels assessed at baseline, immediately after PR, and 6-months were compared between groups using linear mixed models and intention-to-treat analysis.
Measurements And Main Results:
Clinically important improvements in cycle endurance time were evident following PR for HIIT and MICT with no between-group difference (MD -63s, 95%CI -195 to 68s). A similar response was seen for 6MWD (MD 4m, 95%C1 -20 to 28m) and all secondary outcomes with no difference between HIIT and MICT. There were no adverse events in either group. A similar proportion of participants in each group completed PR, achieved the prescribed intensity, duration and progression.
Conclusion:
HIIT did not result in greater improvements in exercise endurance than MICT in people with fILD. HIIT was safe and well-tolerated, and may serve as an alternative to MICT in people with fILD.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
